CAMBRIDGE, Mass., Sept. 2, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will present a company overview at several upcoming conferences.
* Steven J. Kafka, Ph.D., vice president, finance, will present at
the Rodman & Renshaw Annual Global Conference in New York City
on September 9, 2009 at 12:30 p.m. EDT.
* Adelene Q. Perkins, president and chief business officer, will
present at the Baird Small Cap Healthcare Conference in New York
City on September 10, 2009 at 3:15 p.m. EDT.
* Steven H. Holtzman, chair and chief executive officer, will
present at the UBS Global Financial Services Conference in
New York City on September 23, 2009 at 2:00 p.m. EDT.
A live webcast of Infinity's presentations will be accessible on the company's website at http://www.infi.com.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging cancer pathways. Infinity's two most advanced programs in Hsp90 inhibition and Hedgehog signaling pathway inhibition are evidence of its innovative approach to oncology drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.